This week, gene therapies for achromatopsia and Stargardt gain the FDA’s attention, a betamethasone-based treatment for postoperative pain and inflammation shows promise and a new study reveals the danger of hand sanitizers among children. Source: AAO
In this prospective pilot study, the authors investigated the safety and efficacy of corneal minimized-volume ablation with accelerated CXL in eyes with keratoconus. Source: AAO
This week, a travoprost intracameral implant shows encouraging phase 1 results, the ILM could play a key role in repairing damaged retinas and acupuncture treatment leaves a patient seeing lights. Source: AAO
This 28-year retrospective chart review reports the outcomes of goniosurgery for children with glaucoma associated with Sturge-Weber syndrome. Source: AAO
This week, Glaukos reports positive results from 2 glaucoma trials, CorNeat Vision’s artificial cornea is implanted into its first trial participant and Notal Vision tests out their at-home OCT platform for monitoring AMD. Source: AAO
This multicenter, prospective case series evaluated changes in ongoing immunomodulatory and biologic therapies used for noninfectious uveitis during the COVID-19 pandemic. Source: AAO
This retrospective, interventional case series evaluated the long-term safety and efficacy of accelerated transepithelial CXL in pediatric eyes with progressive keratoconus. Source: AAO
This week, faricimab shines in phase 3 studies for DME, a case of frosted branch angiitis after a stem cell transplant and physicians search for the source of a free-floating pigmented intravitreal cyst. Source: AAO
This single-center retrospective study analyzes consultations managed by an ophthalmic hospitalist covering a children’s hospital. Source: AAO
Researchers compared the 5-year efficacy and safety of accelerated transepithelial and standard CXL in children with progressive keratoconus. Source: AAO